{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:52Z","timestamp":1753891912443,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Medical research continues to be extensively devoted to investigating the pathogenesis and treatment approaches of hereditary renal cancer. By aspect including researchers, institutions, countries, journals, and keywords, we conduct a bibliometric analysis of the literature pertaining to hereditary renal cancer over the last 23 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From the Web of Science Core Collection, we conducted a search for publications published between January 1, 2000 and November 28, 2023. Reviews and original articles were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A cumulative count of 2,194 publications met the specified criteria for inclusion. The studies of the included articles involved a collective of 2,402 institutions representing 80 countries. Notably, the United States exhibited the highest number of published documents, constituting approximately 45.49% of the total. The preeminent institution in this discipline is the National Cancer Institute (NCI), which maintains a publication volume of 8.98%. In addition to being the most prolific author (125 publications), Linehan WM\u2019s works received the highest number of citations (11,985). In a comprehensive count, 803 journals have published related articles. In the top 10 most recent occurrences were the terms \u201chereditary leiomyomatosis\u201d and \u201cfumarate hydratase.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first bibliometric analysis of the literature on hereditary renal cancer. This article offers a thorough examination of the present status of investigations concerning hereditary renal cancer during the previous 23 years.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1364997","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T04:27:47Z","timestamp":1717388867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaopeng","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.23.00104","article-title":"Osteosarcoma explorer: A data commons with clinical, genomic, protein, and tissue imaging data for osteosarcoma research","volume":"7","author":"Yang","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: Patterns and predictors of metastases-A contemporary population-based series","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1773-y","article-title":"Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study","volume":"34","author":"Dabestani","year":"2016","journal-title":"World J Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2020.04.003","article-title":"Update on hereditary renal cancer and imaging implications","volume":"58","author":"Walker","year":"2020","journal-title":"Radiol Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/his.14641","article-title":"The pathological and molecular genetic landscape of the hereditary renal cancer predisposition syndromes","volume":"81","author":"Al-Obaidy","year":"2022","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2023.01.010","article-title":"Diseases of hereditary renal cell cancers","volume":"50","author":"Iliopoulos","year":"2023","journal-title":"Urol Clin North Am"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3171\/2021.3.JNS204203","article-title":"Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement","volume":"136","author":"Huntoon","year":"2021","journal-title":"J Neurosurg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tau","article-title":"Natural history and growth kinetics of clear cell renal cell carcinoma in sporadic and von Hippel-Lindau disease","volume":"10","author":"Li","year":"2021","journal-title":"Transl Androl Uro"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0491","article-title":"The role of aberrant VHL\/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma","volume":"19","author":"Choueiri","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33978","article-title":"Management recommendations for pancreatic manifestations of von Hippel-Lindau disease","volume":"128","author":"Laks","year":"2022","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review","volume":"16","author":"Chayed","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22905","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening","volume":"60","author":"Garg","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13503","article-title":"Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation","volume":"109","author":"Hasumi","year":"2018","journal-title":"Cancer Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2018.07.010","article-title":"Recognizing hereditary renal cancers through the microscope: A pathology update","volume":"11","author":"Peng","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ijo","article-title":"Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear-cell renal cell carcinoma treated with sunitinib as first-line treatment","volume":"55","author":"Wierzbicki","year":"2019","journal-title":"Int J Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253847","article-title":"TeamTree analysis: A new approach to evaluate scientific production","volume":"16","author":"Pfrieger","year":"2021","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120855","article-title":"Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers","volume":"129","author":"Chappell","year":"2019","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.338","article-title":"The HIF and other quandaries in VHL disease","volume":"37","author":"Tarade","year":"2018","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1158\/1078-0432.CCR-22-2968","article-title":"FDA approval summary: belzutifan for VHL disease tumors-letter","volume":"29","author":"Trinh","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v13","article-title":"Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy","volume":"13","author":"Ueno","year":"2022","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206955","article-title":"HOOK1 inhibits the progression of renal cell carcinoma via TGF-\u03b2 and TNFSF13B\/VEGF-A axis","volume":"10","author":"Yin","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.3390\/ijms21155567","article-title":"Cell sheets from adipose tissue MSC induce healing of pressure ulcer and prevent fibrosis via trigger effects on granulation tissue growth and vascularization","volume":"21","author":"Alexandrushkina","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.jbc.2022.101833","article-title":"Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development","volume":"298","author":"Tamura","year":"2022","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04344-9","article-title":"Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome","volume":"41","author":"Cerrato","year":"2023","journal-title":"World J Urol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2243669","DOI":"10.1080\/21645515.2023.2243669","article-title":"Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003\u20132022","volume":"19","author":"Zhu","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21037\/tau","article-title":"Research of targeted therapy for renal cancer from 2006 to 2022: a bibliometric and visualized analysis","volume":"12","author":"Gou","year":"2023","journal-title":"Transl Androl Urol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2035552","DOI":"10.1080\/21645515.2022.2035552","article-title":"Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer","volume":"18","author":"He","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13179","DOI":"10.3390\/ijms241713179","article-title":"Cancer stem cells in renal cell carcinoma: origins and biomarkers","volume":"24","author":"Lasorsa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.3390\/ijms24054615","article-title":"Radiogenomics in renal cancer management-current evidence and future prospects","volume":"24","author":"Ferro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03635-9","article-title":"Evolution of hormesis research: a bibliometric analysis","volume":"98","author":"Agathokleous","year":"2024","journal-title":"Arch Toxicol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1364997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:18:07Z","timestamp":1721384287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1364997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":31,"alternative-id":["10.3389\/fonc.2024.1364997"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1364997","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"article-number":"1364997"}}